Abstract
TEL (Translocation–ETS–Leukemia or ETV 6) is disrupted by multiple chromosomal translocations in acute leukemia. The loss of heterozygosity at the TEL locus in leukemias and the hemizygous deletion of TEL that is observed in various tumors, suggests that TEL is a tumor suppressor. Overexpression of TEL alters cellular morphology and represses the expression of the matrix metalloproteinase stromelysin-1. Based on these studies, deletion analysis was used to define the minimal repression domains of TEL. TEL-mediated repression required both the N-terminal pointed domain and a central region composed of amino acids 268–303. The mSin3A and N-CoR corepressors bind to the pointed domain and the central repression domain of TEL, respectively. Unexpectedly, histone deacetylase-3, but not other histone deacetylases, also associates with the central region of TEL. Histone deacetylase-3 interacts with a TEL mutant that cannot bind N-CoR, suggesting that this is a direct interaction with TEL. In addition, histone H3 was under-acetylated near the TEL-binding sites in the endogenous stromelysin-1 promoter when TEL was expressed. Furthermore, trichostatin A, a potent histone deacetylase inhibitor, impaired TEL-dependent repression of the stromelysin-1 promoter. Finally, while TEL-expression induced cellular aggregation of Ras-transformed cells, Trichostatin A reversed the TEL-induced cellular aggregation phenotype. Thus, the cumulative data suggests that histone deacetylase-3 activity is required for the transcriptional functions of TEL.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alland L, Muhle R, Hou Jr H, Potes J, Chin L, Schreiber-Agus N, DePinho RA . 1997 Nature 387: 49–55
Ayer DE, Lawrence QA, Eisenman RN . 1995 Cell 80: 767–776
Basbaum CB, Werb Z . 1996 Curr. Opin. Cell Biol. 8: 731–738
Braunstein M, Rose AB, Holmes SG, Allis CD, Broach JR . 1993 Genes Dev. 7: 592–604
Caelles C, Heimberg A, Karin M . 1994 Nature 370: 220–223
Chakrabarti SR, Nucifora G . 1999 Biochem. Biophys. Res. Commun. 264: 871–877
Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR . 1991 Cell 65: 1053–1061
Chen JD, Evans RM . 1995 Nature 377: 454–457
Chen JD, Umesono K, Evans RM . 1996 Proc. Natl. Acad. Sci. USA 93: 7567–7571
Cress WD, Seto E . 2000 J. Cell Physiol. 184: 1–16
Dedon PC, Soults JA, Allis CD, Gorovsky MA . 1991 Anal. Biochem. 197: 83–90
Emiliani S, Fischle W, Van Lint C, Al-Abed Y, Verdin E . 1998 Proc. Natl. Acad. Sci. USA 95: 2795–2800
Fenrick R, Amann J, Lutterbach B, Wang L, Westendorf JJ, Downing J, Hiebert SW . 1999 Mol. Cell Biol. 19: 6566–6574
Fenrick R, Wang L, Nip J, Amann JM, Rooney RJ, Walker-Daniels J, Crawford HC, Hulboy DL, Kinch MS, Matrisian LM, Hiebert SW . 2000 Mol. Cell. Biol. 20: 5828–5839
Fischle W, Emiliani S, Hendzel MJ, Nagase T, Nomura N, Voelter W, Verdin E . 1999 J. Biol. Chem. 274: 11713–11720
Golub TR, Barker GR, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG . 1995 Proc. Natl. Acad. Sci. USA 92: 4917–4921
Golub TR, Barker GF, Lovett M, Galliland DG . 1994 Cell 77: 307–316
Graves BJ, Petersen JM . 1998 Advances in Cancer Research 75: 1–55
Grozinger CM, Hassig CA, Schreiber SL . 1999 Proc. Natl. Acad. Sci. USA 96: 4868–4873
Guarente L . 2000 Genes Dev. 14: 1021–1026
Guenther MG, Lane WS, Fischle W, Verdin E, Lazar MA, Shiekhattar R . 2000 Genes Dev. 14: 1048–1057
Guidez F, Petrie K, Ford AM, Lu H, Bennett CA, MacGregor A, Hannemann J, Ito Y, Ghysdael J, Greaves M, Wiedemann LM, Zelent A . 2000 Blood 96: 2557–2561
Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE . 1997 Cell 89: 341–347
Hatta Y, Takeuchi S, Yokota J, Koeffler HP . 1997 Br. J. Cancer 75: 1256–1262
Haupt Y, Rowan S, Shaulian E, Vousden KH, Oren M . 1995 Genes and Dev. 9: 2170–2183
Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG . 1997 Nature 387: 43–48
Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Rosenfeld MG, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG . 1995 Nature 377: 397–404
Hu E, Chen Z, Fredrickson T, Zhu Y, Kirkpatrick R, Zhang GF, Johanson K, Sung CM, Liu R, Winkler J . 2000 J. Biol. Chem. 275: 15254–15264
Huang EY, Zhang Y, Miska EA, Guenther MG, Kouzarides T, Lazar MA . 2000 Genes Dev. 14: 45–54
Imai S, Armstrong CM, Kaeberlein M, Guarente L . 2000 Nature 403: 795–800
Javed A, Guo B, Hiebert S, Choi JY, Green J, Zhao SC, Osborne MA, Stifani S, Stein JL, Lian JB, van Wijnen AJ, Stein GS . 2000 J. Cell Sci. 113: 2221–2231
Kadosh D, Struhl K . 1997 Cell 89: 365–371
Kao HY, Downes M, Ordentlich P, Evans RM . 2000 Genes Dev. 14: 55–66
Kurokawa R, Soderstrom M, Horlein A, Halachmi S, Brown M, Rosenfeld MG, Glass CK . 1995 Nature 377: 451–445
Kwiatkowski BA, Bastian LS, Bauer Jr TR, Tsai S, Zielinska-Kwiatkowska AG, Hickstein DD . 1998b J. Biol. Chem. 273: 17525–17530
Laherty CD, Yang WM, Sun JM, Davie JR, Seto E, Eisenman RN . 1997 Cell 89: 349–356
Landry J, Sutton A, Tafrov ST, Heller RC, Stebbins J, Pillus L, Sternglanz R . 2000 Proc. Natl. Acad. Sci. USA 97: 5807–5811
Levanon D, Goldstein RE, Bernstein Y, Tang H, Goldenberg D, Stifani S, Paroush Z, Groner Y . 1998 Proc. Natl. Acad. Sci. USA 95: 11590–11595
Li J, Wang J, Nawaz Z, Liu JM, Qin J, Wong J . 2000 EMBO J. 19: 4342–4350
Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, Bissell MJ . 1997 J Cell Biol. 139: 1861–1872
Lopez RG, Carron C, Oury C, Gardellin P, Bernard O, Ghysdael J . 1999 J. Biol. Chem. 274: 30132–30138
Luo RX, Dean DC . 1999 J. Natl. Cancer Inst. 91: 1288–1294
Luo RX, Postigo AA, Dean DC . 1998 Cell 92: 463–473
Lutterbach B, Westendorf JJ, Linggi B, Isaac S, Seto E, Hiebert SW . 2000 J. Biol. Chem. 275: 651–656
Lutterbach B, Westendorf JJ, Linggi B, Patten A, Moniwa M, Davie JR, Huynh KD, Bardwell VJ, Lavinsky RM, Glass CK, Rosenfeld MG, Seto E, Hiebert SW . 1998 Mol. Cell Biol. 18: 7176–7184
Mahlknecht U, Bucala R, Hoelzer D, Verdin E . 1999 Cytogenet Cell Genet. 86: 237–239
Miska EA, Karlsson C, Langley E, Nielsen SJ, Pines J, Kouzarides T . 1999 EMBO J. 18: 5099–5107
Murphy M, Ahn J, Walker KK, Hoffman WH, Evans RM, Levine AJ, George Dl . 1999 Genes Dev. 13: 2490–2501
Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, Ayer DE, Schreiber SL, Evans RM . 1997 Cell 89: 373–380
Pazin MJ, Kadonaga JT . 1997 Cell 89: 325–328
Poirel H, Lopez RG, Lacronique V, Della Valle V, Mauchauffe M, Berger R, Ghysdael J, Bernard OA . 2000 Oncogene 19: 4802–4806
Potter MD, Buijs A, Kreikder B, van Rompaey L, Grosveld GC . 2000 Blood 95: 3341–3348
Rao G, Alland L, Guida P, Schreiber-Agus N, Chen K, Chin L, Rochelle JM, Seldin MF, Skoultchi AI, DePinho RA . 1996 Oncogene 12: 1165–1172
Raynaud S, Cave H, Baens M, Bastard C, Cacheux V, Grosgeorge J, Guidal-Giroux C, Guo C, Vilmer E, Marynen P, Grandchamp B . 1996 Blood 87: 2891–2899
Romana SP, Le Coniat M, Poirel H, Marynen P, Bernard O, Berger R . 1996 Leukemia 10: 167–170
Scholz H, Deatrick J, Klaes A, Klambt C . 1993 Genetics 135: 455–468
Spirin KS, Simpson JF, Takeuchi S, Kawamata N, Miller CW, Koeffler HP . 1996 Cancer Research 56: 2400–2404
Stegmaier K, Pendse S, Barker GF, Bray-Ward P, Ward DC, Montgomery KT, Krauter KS, Reynolds C, Sklar J, Donnelly M . 1995 Blood 86: 38–44
Struhl K . 1998 Genes Dev. 12: 599–606
Taunton J, Hassig CA, Schreiber SL . 1996 Science 272: 408–411
Van Rompaey L, Dou W, Buijs A, Grosveld G . 1999 Neoplasia 1: 526–536
Van Rompaey L, Potter M, Adams C, Grosveld G . 2000 Oncogene 19: 5244–5250
Verdel A, Khochbin S . 1999 J. Biol. Chem. 274: 2440–2445
Vidal M, Strich R, Exposito RE, Gaber RF . 1991 Mol. Cell Biol. 11: 6306–6316
Wang LC, Kuo F, Fujiwara Y, Gilliland DG, Golub TR, Orkin SH . 1997 EMBO J. 16: 4374–4383
Wang LC, Swat W, Fujiwara Y, Davidson L, Visvader J, Kuo F, Alt FW, Gilliland DG, Golub TR, Orkin SH . 1998 Genes Dev. 12: 2392–2402
Wen YD, Perissi V, Staszewski LM, Yang WM, Krones A, Glass CK, Rosenfeld MG, Seto E . 2000 Proc. Natl. Acad. Sci. USA 97: 7202–7207
Wiesen JF, Werb Z . 1996 Enzyme and Protein 49: 174–181
Wong CW, Privalsky ML . 1998 Mol. Cell Biol. 18: 5500–5510
Yang WM, Yao YL, Sun JM, Davie JR, Seto E . 1997 J. Biol. Chem. 272: 28001–28007
Zhang Y, Iratni R, Erdjument-Bromage H, Tempst P, Reinbert D . 1997 Cell 89: 357–364
Acknowledgements
We thank Yue Hou for technical assistance, and members of the Hiebert laboratory for helpful discussions and especially Drs Joseph Amann and Lauren Wood for critically reading the manuscript. The experiments described here were performed in part through the use of the VICC sequencing facility, which is supported by NIH grant CA68465. This work was also supported by NIH/NCI grant RO1-CA77274 (to SW Hiebert), and by the Vanderbilt-Ingram Cancer Center.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wang, L., Hiebert, S. TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3. Oncogene 20, 3716–3725 (2001). https://doi.org/10.1038/sj.onc.1204479
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204479
Keywords
This article is cited by
-
The ETS transcription factor ETV6 constrains the transcriptional activity of EWS–FLI to promote Ewing sarcoma
Nature Cell Biology (2023)
-
Etv6 activates vegfa expression through positive and negative transcriptional regulatory networks in Xenopus embryos
Nature Communications (2019)
-
Development and evolution of gut structures: from molecules to function
Cell and Tissue Research (2019)
-
NCoR negatively regulates adipogenic differentiation of mesenchymal stem cells
In Vitro Cellular & Developmental Biology - Animal (2015)
-
Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks
The EMBO Journal (2008)